On the mechanism of tolerance to morphine-induced Straub tail reaction in mice

M R Zarrindast1, K Alaei-Nia, M Shafizadeh

  • 1Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, PO Box 13145-784, Tehran, Iran.

Insights

Opioid and serotonin antagonists reduce morphine-induced Straub tail and tolerance in mice. These findings suggest 5-HT(2) and opioid receptors are key mechanisms in morphine

Area of Science:

  • Neuropharmacology
  • Pain Research

Background:

  • Morphine is a widely used analgesic.
  • The Straub tail phenomenon is a characteristic behavioral response to morphine administration in rodents.
  • Understanding the neurobiological underpinnings of morphine's effects is crucial for optimizing its therapeutic use and managing side effects.

Purpose of the Study:

  • To investigate the involvement of serotonin (5-HT) and opioid receptors in morphine-induced Straub tail behavior in mice.
  • To examine the role of these receptors in the development of tolerance to morphine.

Main Methods:

  • Straub tail behavior was induced in mice using various doses of morphine hydrochloride.
  • The effects of opioid receptor antagonists (naloxone) and serotonin receptor antagonists (methysergide, mianserin, ritanserin) were assessed following systemic and central administration.
  • Morphine tolerance was induced by repeated daily administration of morphine sulfate, and the influence of antagonists on this tolerance was evaluated.

Main Results:

  • Morphine-induced Straub tail was dose-dependent, with the maximum response at 40 mg/kg.
  • Both naloxone and serotonin antagonists significantly reduced morphine-induced Straub tail.
  • Administration of these antagonists also attenuated the development of morphine tolerance, both when given during tolerance induction and before testing.

Conclusions:

  • Serotonin 5-HT(2) and opioid receptor systems play a significant role in mediating the Straub tail response to morphine.
  • The development of tolerance to morphine may also involve these serotonergic and opioid receptor pathways.